Clinical Trial Update: Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts in Adolescents [Phase 1]

View source ↗

Summary

Phase 1 safety study of sublingual immunotherapy tablets containing house dust mite allergen extract in adolescents with allergic rhinitis. The trial is complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Sublingual immunotherapy tablet (house dust mite allergen extract) (house dust mite allergen extract tablet)

Snippet

Sponsor: Stallergenes Greer | Conditions: Allergic Rhinitis Due to House Dust Mite | Phase 1 | Status: COMPLETED | Results posted: 2025-01-17